research Assessment of selective elements in serum and hair samples of women with post-COVID-19 alopecia: copper significance
Copper deficiency is linked to post-COVID-19 hair loss in women.
Search
forProducts matching "female alopecia"
Tracking 2 products like 151 Tugain 5 Solution (Minoxidil 5%) and 152 Tugain 10 Solution (Minoxidil 10%) from by companies like Inhouse Pharmacy. View all 2 products »
Sort by
Research
480-510 / 1000+ results 
research The Enigma of the Stigma of Hair Loss: Why is Cancer-Treatment Related Alopecia so Traumatic for Women?
Hair loss from cancer treatment is very distressing for women due to its impact on self-image and social stigma.
research Estradiol‐induced alopecia in five dogs after contact with a transdermal gel used for the treatment of postmenopausal symptoms in women
Estradiol gel can cause hair loss in dogs.
research Alopecia en mujeres con obesidad severa y mórbida sometidas a cirugía bariátrica Alopecia in women with severe and morbid obesity who undergo bariatric surgery
Higher zinc and iron intake leads to less hair loss after bariatric surgery.
research Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles
Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.
research Experience of Novelty Laser Therapy Emission with 675 nm Wavelength for the Treatment of Androgenetic Alopecia in Male and Female Patients: A Case Series Study
The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.
research Prevalence of androgenic alopecia in 14- to 18-year-old female high school students in Shiraz
research Clinical Signs and Laboratory Tests for the Differential Diagnosis ofAndrogenic and Post-COVID-19 Alopecia in Women
Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.
research Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
Some drugs linked to growth hormones may increase the chance of hair loss in women.
research Treatment of low serum ferritin in females with alopecia by oral iron.
Iron supplements can help reduce hair loss in women with low iron levels.
research Faculty Opinions recommendation of A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
5% minoxidil foam used once daily is as effective as 2% minoxidil solution used twice daily for hair loss in women, but with fewer side effects like itching and dandruff.
research Association of frontal fibrosing alopecia and contact allergens in everyday skincare products in Hispanic females: a case-control study
Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.
research Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
Finasteride has a higher risk of reproductive side effects than minoxidil.
research Involvement of the bulge region with decreased expression of hair follicle stem cell markers in senile female cases of alopecia areata
Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.
research Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata
The tool to measure life quality for women with alopecia is reliable and accurate.
research Psychological outcomes after hair transplant in women with androgenetic alopecia
research Low‐dose oral minoxidil in women affected by traction alopecia: real‐world outcomes
research Use of trichoscopy for the diagnosis of alopecia areata coexisting with primary scarring alopecia in a female hair loss patient
Trichoscopy helped diagnose and treat a woman with two different types of hair loss.
research The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study
Dr. SKS Hair Booster Serum is safe and effective for reducing hair fall and promoting hair growth.
research The mechanism of inheritance of androgenetic alopecias in women
research Evidence of Increased 3‐Alpha‐Androstanediol Glucuronide in Female Pattern Alopecia: A Cross‐Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens
Higher levels of 3α-diol G are linked to more severe female pattern hair loss.
research The Effect of Platelet-rich Plasma in Treating Androgenic Alopecia in Female Libyan Patients with Curly Hair
research ISID0503 – Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
research Acute telogen effluvium in 503 female patients: The value of the effluvium triggering cause to predict female androgenetic alopecia association
research Effect of biotin on hair roots and sebum excretion in women with diffuse alopecia.
research [Effect of biotin on hair roots and sebum excretion in females with diffuse alopecia].
research Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient
research What’s new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
research [Comments on the paper: “Studies on the etiology of androgenetic alopecia in the female” by E. Vadász and M. Debreczeni (Hautarzt 18, 454-456, 1967)].
Unable to summarize as the text doesn't provide a conclusion.